The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer by unknown
RESEARCH ARTICLE Open Access
The prognostic significance of the
postoperative prognostic nutritional index
in patients with colorectal cancer
Masatsune Shibutani*, Kiyoshi Maeda, Hisashi Nagahara, Hiroshi Ohtani, Yasuhito Iseki, Tetsuro Ikeya,
Kenji Sugano and Kosei Hirakawa
Abstract
Background: The preoperative prognostic nutritional index (PNI) has been reported to correlate with the prognosis
in patents with various carcinomas. However, the prognostic significance of the postoperative PNI is unknown. The
aim of this study was to evaluate the prognostic significance of the postoperative PNI in patients with colorectal
cancer (CRC).
Methods: Two hundred and eighteen patients who underwent potentially curative surgery for stage II/III CRC were
enrolled in this study. The PNI was calculated as 10 × serum albumin concentration (g/dl) + 0.005 × lymphocyte
count (/mm3). The preoperative PNI was measured within two weeks before the operation and the postoperative
PNI were measured at the first visit after leaving the hospital. We then examined the correlations between the
preoperative/postoperative PNI and the prognosis for survival.
Results: In the validation study, the median preoperative PNI was 47.90 (range: 32.45-61.36) and the median
postoperative PNI was 48.69 (range: 32.62-66.96). According to the receiver operating characteristic (ROC) curve, we
set 43.0 as the cut-off value in the validation study. For both the preoperative and postoperative PNI, the overall
survival rates were significantly worse in the low PNI group in the validation study (preoperative PNI, p = 0.0374;
postoperative PNI, p = 0.0005). In the multivariate analysis of the validation study, the combination of pre- and
postoperative PNI was an independent predictor of poor overall survival (p = 0.006).
Conclusions: The postoperative PNI is, in addition to the preoperative PNI, a useful prognostic marker. The
combination of pre- and postoperative PNI was an independent prognostic factor in patients with CRC who
underwent potentially curative surgery and is important for considering the long-term outcome in patients with CRC.
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Background
Colorectal cancer (CRC) is the third leading cause of
cancer-related death worldwide [1]. Although the surgi-
cal procedures and chemotherapy have improved, a large
number of patients relapse after curative resection, and
the mortality from colorectal cancer is still high. There-
fore, there has been a new focus on identifying bio-
markers that can predict the prognosis. Although much
attention has been paid to the factors related to the
tumor in previous reports, increasing attention has re-
cently been paid to the factors related to the host [2].
Among them, the prognostic nutritional index (PNI),
which indicates the nutritional and immunological status
of the host, and which has been used to predict the risk
of complications after gastrointestinal surgery [3, 4], has
been reported to correlate with survival in various types
of cancer [5–9]. However, most of these reports investi-
gated the preoperative status, and there have been no re-
ports on the relationship between the postoperative PNI
and the long-outcome after potentially curative surgery
for CRC. The aim of this retrospective study was to
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evaluate the prognostic significance of the postoperative
PNI in patients with CRC.
Methods
Patients
We retrospectively reviewed a database of 263 patients
who underwent potentially curative surgery for stage II/
III CRC at the Department of Surgical Oncology of
Osaka City University between 2005 and 2011. We ex-
cluded 10 patients with ulcerative colitis, nine patients
who had received preoperative therapy and 26 patients
with multiple malignancies within five years. Therefore,
218 patients remained and were analyzed in this study.
All patients were followed up regularly with physical
and blood examinations and mandatory screening using
colonoscopy and computed tomography until June 2014
or death. Among the total 218 of patients, sixty-nine pa-
tients developed recurrent disease and 31 patients died.
The resected specimens were pathologically classified
according to the seventh edition of the Union for Inter-
national Cancer Control TNM classification of malig-
nant tumors [10].
All patients were divided into two groups: including
the exploratory group, which consisted of 32 patients
who underwent surgery in 2005; and the validation
group, which consisted of 186 patients who underwent
surgery between 2006 and 2011.
PNI
The preoperative blood samples were obtained within
two weeks before the operation and the postoperative
blood samples were obtained at the first visit after leav-
ing the hospital. The PNI was calculated as 10 × serum
albumin concentration (g/dl) + 0.005 × lymphocyte count
(/mm3).
Statistical analysis
The data were tested for normality by the Kolmogorov-
Smirnov test. The significance of the correlations between
the preoperative/postoperative PNI and the clinicopatho-
logical characteristics was analyzed using the χ2 test. The
duration of survival was calculated according to the
Kaplan-Meier method. Differences in the survival curves
were assessed with the log-rank test. A multivariate ana-
lysis was performed according to the Cox proportional
hazard model. All statistical analyses were conducted
using the SPSS software package for Windows (SPSS
Japan, Tokyo, Japan). Statistical significance was set at a
value of p <0.05.
Ethical consideration
This research was conformed to the provisions of the
Declaration of Helsinki in 1995. All patients were in-
formed of the investigational nature of this study and
provided written informed consent. This retrospective
study was approved by the ethics committee of Osaka
City University.
Results
Clinical characteristics in the exploratory study
The patient characteristics are listed in Table 1. The pa-
tient population consisted of 20 males and 12 females,
with a median age of 69 years (range: 42 to 86). Sixteen
patients had tumors located in the colon and 16 had tu-
mors located in the rectum. Among the total 32 of pa-
tients, fifteen patients received adjuvant chemotherapy.
All of these patients received monotherapy using an oral
prodrug based on 5-FU.
Survival analysis according to the pre-/postoperative PNI
in the exploratory study
The median preoperative PNI was 44.67 (range: 31.76-
60.24) and the median postoperative PNI was 50.16
(range: 31.89-60.75) (Table 1). The PNI distribution was
normal. According to the receiver operating characteris-
tic (ROC) curve, we set 45.0 as the cut-off value (the
sensitivity was 91.7 % and the specificity was 87.5 %)
(Fig. 1). Based on the cut-off value of 45.0, 13 patients
were classified into the high preoperative PNI group and
16 patients were classified into the low preoperative PNI
group. Moreover, 23 patients were classified into the
high postoperative PNI group and 9 patients were classi-
fied into the low postoperative PNI group. With regard
to the preoperative PNI, the overall survival rates were
significantly worse in the low PNI group compared to
the high PNI group (p = 0.0303) (Fig. 2). Moreover, the
overall survival rates were also significantly worse in the
low postoperative PNI group (p < 0.0001) (Fig. 3).
Survival analysis according to the combination of the
preoperative and postoperative PNI in the exploratory
study
We categorized the patients into four groups according
to the combination of their preoperative and postopera-
tive PNI. The patients with high preoperative and post-
operative PNI were categorized into group A. The
patients with a high preoperative PNI and a low postop-
erative PNI were categorized into group B. The patients
with a low preoperative PNI and a high postoperative
PNI were categorized into group C, and the patients
with a low preoperative and a low postoperative PNI
were categorized into group D. The patients in group A
exhibited a better prognosis than those in groups B and
D (A vs. B, p = 0.0005; A vs. D, p = 0.0003). The patients
in group C exhibited a better prognosis than those in
group D (C vs. D, p = 0.0163) (Fig. 4).
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The correlations between the preoperative/postoperative
PNI and the clinicopathological factors in the exploratory
study
The preoperative PNI had a significant relationship with
age (p = 0.008) and the number of hospitalization days
(p = 0.027) (Table 2). The postoperative PNI had no sig-
nificant relationships with any factors.
Prognostic factors influencing the long-term survival in
the exploratory study
The correlations between the overall survival and vari-
ous clinicopathological factors are shown in Table 3.
According to a univariate analysis, the overall survival
had significant relationships with the combination of
pre and postoperative PNI (p = 0.013) and the number
of lymph node metastases (p = 0.008). A multivariate
analysis indicated that the combination of pre and post-
operative PNI (p = 0.030), the number of lymph node
Table 1 The patient characteristics
Exploratory
Group (n = 32)
Validation





Median (range) 69 (42–86) 67 (26–86)







Well, Moderately 27 172
Poorly, Mucinous 5 14











The amount of blood lost (ml)
Median (range) 245 (5–1780) 97.5 (5–2700)
Length of operation (min)




Regimen of adjuvant chemotherapy
Monotherapy using an oral
pro-drug based on 5-FU
15 126














Table 1 The patient characteristics (Continued)
The number of hospitalization days
Median (Interquartile range) 30 (25–39) 17 (13–24)
The number of postoperative
days before the initiation of
dietary intake (days)
Median (Interquartile range) 4 (3–6) 3 (2–4)
The number of days from
operation to the first hospital visit
Median (Interquartile range) 31 (26–36) 28 (22–35)
CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19–9, PNI
prognostic nutritional index
Fig. 1 Receiver operating characteristic curve analysis of the
postoperative PNI in the exploratory study. Area under the
curve = 0.974, 95 % Confidence interval = 0.927-1.021, p < 0.001
Shibutani et al. BMC Cancer  (2015) 15:521 Page 3 of 10
metastases (p = 0.021) and the adjuvant chemotherapy
(p = 0.044) were independent risk factors for mortality.
Clinical characteristics in the validation study
The patient characteristics are listed in Table 1. The pa-
tient population consisted of 100 males and 86 females,
with a median age of 67 years (range: 26 to 86). Ninety-
four patients had tumors located in the colon and 92
had tumors located in the rectum. Among the total 186
of patients, one hundred and forty-one patients received
adjuvant chemotherapy. Among these patients, one hun-
dred and twenty-six patients received monotherapy
using an oral pro-drug based on 5-FU, while 15 patients
received combination therapy with 5-FU and oxaliplatin.
Survival analysis according to the pre-/postoperative PNI
in the validation study
The median preoperative PNI was 47.90 (range: 32.45-
61.36) and the median postoperative PNI was 48.69
(range: 32.62-66.96) (Table 1). The PNI distribution was
normal. According to the Receiver Operating Character-
istic (ROC) curve, we set 43.0 as the cut-off value (the
sensitivity was 89.4 % and the specificity was 64.0 %)
(Fig. 5). Based on the cut-off value of 43.0, 106 patients
were classified into the high preoperative PNI group and
23 patients were classified into the low preoperative PNI
group. Moreover, 160 patients were classified into the
high postoperative PNI group and 26 patients were clas-
sified into the low postoperative PNI group. With regard
to the preoperative PNI, the overall survival rates were
significantly worse in the low PNI group compared to
the high PNI group (p = 0.0374) (Fig. 6). Moreover, the
overall survival rates were also significantly worse in the
low postoperative PNI group (p = 0.0005) (Fig. 7).
Survival analysis according to the combination of the
preoperative and postoperative PNI in the validation
study
We categorized the patients into four groups according
to the combination of their preoperative and postopera-
tive PNI in the same manner as the exploratory study.
The patients in group A exhibited a better prognosis
than the patients in groups B and D (A vs. B, p < 0.0001;
A vs. D, p = 0.0001) (Fig. 8).
Fig. 2 The Kaplan-Meier survival curves according to the preoperative
PNI in the exploratory study. The overall survival rates were significantly
worse in the low preoperative PNI group (p = 0.0303)
Fig. 3 The Kaplan-Meier survival curves according to the postoperative
PNI in the exploratory study. The overall survival rates were significantly
worse in the low postoperative PNI group (p < 0.0001)
Fig. 4 The overall survival subdivided according to the preoperative
and postoperative PNI in exploratory study. The patients in group A
exhibited a better prognosis than those in groups B and D (*, p= 0.0005;
***, p= 0.0003). The patients in group C exhibited a better prognosis
than those in group D (**, p= 0.0163)
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Table 2 The relationship between the clinicopathological factors and the preoperative/preoperative PNI in the exploratory study
Preoperative PNI Postoperative PNI
High Low p-value High Low p-value
Gender
Male 10 9 14 6
Female 3 7 0.433 9 3 1.000
Age (years)
≤70 11 5 13 4
>70 2 11 0.008 10 5 0.699
Location of primary tumor
Colon 7 9 13 5
Rectum 6 7 1.000 10 4 1.000
Tumor depth
≤T3 9 6 12 4
T4 4 10 0.139 11 5 1.000
Histological type
Well, Moderately 10 14 20 7
Poorly, Mucinous 3 2 0.632 3 2 0.604
The number of lymph node metastases
0 8 6 14 3
1-3 3 6 6 3
≥4 2 4 0.436 3 3 0.292
Preoperative CEA (ng/ml)
≤5 8 5 11 3
>5 4 10 0.128 10 6 0.440
Preoperative CA19-9 (U/ml)
≤37 6 6 8 5
>37 1 4 0.338 5 1 0.605
The amount of blood lost (ml)
≤250 9 5 12 4
>250 4 10 0.128 10 5 0.704
Length of operation (min)
≤240 11 10 18 6
>240 2 5 0.396 4 3 0.384
Complication(s)
No 11 10 18 6
Yes 2 6 0.238 5 3 0.654
Infectious complication(s)
No 12 14 21 8
Yes 1 2 1.000 2 1 1.000
The number of hospitalization days (days)
≤30 9 4 11 4
>30 4 12 0.027 12 5 1.000
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The correlations between the preoperative/postoperative
PNI and the clinicopathological factors in the validation
study
The preoperative PNI had a significant relationship with
gender (p = 0.012) and age (p = 0.035) (Table 4). The post-
operative PNI had a significant relationship with the num-
ber of hospitalization days (p = 0.035) and the number of
postoperative days to initiate dietary intake (p = 0.034),
and tended to correlate with the preoperative CA19-9
(p = 0.088) and the amount of blood loss (p = 0.094).
Prognostic factors influencing the long-term survival in
the validation study
The correlations between the overall survival and vari-
ous clinicopathological factors are shown in Table 5.
According to a univariate analysis, the overall survival
had significant relationships with the combination of
pre and postoperative PNI (p = 0.001), age (p = 0.001),
histological type (p = 0.004), the number of lymph node
metastases (p < 0.001) and the preoperative CEA level
(p = 0.033). A multivariate analysis indicated that the
combination of pre and postoperative PNI (p = 0.001),
histological type (p = 0.044), the number of lymph node
metastases (p = 0.022) and the preoperative CEA level
(p = 0.037) were independent risk factors for mortality.
Discussion
In this study, we investigated the correlations between
the postoperative PNI and the long-term outcome in pa-
tients with stage II/III CRC. To the best of our know-
ledge, this is the first study to evaluate the prognostic
significance of the postoperative PNI.
The preoperative PNI, which reflects the nutritional
and immunological status of the host and was initially
used as a predictor of complications after digestive sur-
gery, was reported to correlate with the long-term out-
come in patients with esophageal [5], gastric [6],
pancreatic [7] and colorectal cancer [8, 9]. Although the
prognostic significance of the preoperative PNI has been
reported, there have been few reports which have fo-
cused on the prognostic significance of the postoperative
PNI. Based on the results of the present study, the post-
operative status was also considered to correlate with
the long-term outcome. Moreover, the combination of
the preoperative and postoperative PNI enabled a more
accurate stratification of the risk for a poor prognosis.
Table 2 The relationship between the clinicopathological factors and the preoperative/preoperative PNI in the exploratory study
(Continued)
The number of postoperative days before the initiation of dietary intake (days)
≤4 10 9 16 5
>4 3 7 0.433 7 4 0.681
Adjuvant chemotherapy
No 5 9 10 5
Yes 8 7 0.462 13 4 0.699
CI confidence interval, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19–9, PNI prognostic nutritional index
Table 3 The correlations between the overall survival and various clinicopathological factors in the exploratory study
Univariate analysis Multivariate analysis
Hazard Ratio 95 % CI p-value Hazard Ratio 95 % CI p-value
Age (>70 years) 4.143 0.832–20.641 0.083 0.616 0.054–6.992 0.696
Gender (Female) 0.998 0.238–4.178 0.998
Location of primary tumor (Rectum) 1.260 0.315–5.040 0.744
Tumor depth (T4) 1.044 0.261–4.177 0.951 0.098 0.004–2.233 0.145
Histological type (Poorly, Mucinous) 1.929 0.389–9.571 0.422 0.928 0.064–13.370 0.956
The number of lymph node metastases (≥4) 6.656 1.643–26.960 0.008 21.560 1.584–293.440 0.021
Preoperative CEA (>5 ng/ml) 3.218 0.648–15.975 0.153 13.475 0.281–645.979 0.188
Preoperative CA19-9 (>37 U/ml) 1.023 0.187–5.602 0.979
Adjuvant chemotherapy (None) 1.540 0.368–6.447 0.555 13.021 1.076–157.523 0.044
The amount of blood lost (>250 ml) 1.896 0.453–7.942 0.381
Combination of pre and postoperative PNI (<45) 3.770 1.316–10.801 0.013 6.728 1.200–37.716 0.030
CI confidence interval, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19–9, PNI prognostic nutritional index
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The PNI can be easily calculated from the serum albumin
concentration and the lymphocyte count, which are stand-
ard parameters assessed in the clinical setting. Although
the details of the relationship between a low PNI and a
poor prognosis are currently unclear, the mechanism(s) is
considered to include the following: Hypoalbuminemia re-
flects malnutrition in the patient [11], and malnutrition has
been reported to correlate with an immunosuppressed
condition [12, 13]. In some previous reports, hypoalbumin-
emia itself was reported to be a prognostic factor for a poor
survival in patients with malignancies [14–16]. Moreover,
lymphopenia was also previously reported to be a prognos-
tic factor for poor survival in patients with malignant dis-
ease [17, 18]. The low lymphocyte count is associated with
a preexisting immunosuppressed condition, suggesting that
the host has an inadequate anti-tumor immunological reac-
tion [19, 20]. Therefore, lymphopenia creates a favorable
microenvironment for recurrence [21]. Taken together, the
Fig. 5 Receiver operating characteristic curve analysis of the
postoperative PNI in the validation study. Area under the curve = 0.727,
95 % Confidence interval = 0.612-0.842, p < 0.001
Fig. 6 The Kaplan-Meier survival curves according to the preoperative
PNI in the validation study. The overall survival rates were significantly
worse in the low preoperative PNI group (p = 0.0374)
Fig. 7 The Kaplan-Meier survival curves according to the postoperative
PN in the validation study. The overall survival rates were significantly
worse in the low postoperative PNI group (p = 0.0005)
Fig. 8 The overall survival subdivided according to the preoperative
and postoperative PNI in the validation study. The patients in group
A exhibited a better prognosis than those in groups B and D
(*, p = 0.0001; **, p < 0.0001)
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Table 4 The relationship between the clinicopathological factors and the preoperative/preoperative PNI in the validation study
Preoperative PNI Postoperative PNI
High Low p-value High Low p-value
Gender
Male 52 18 87 13
Female 54 5 0.012 73 13 0.679
Age (years)
≤70 65 8 99 16
>70 41 15 0.035 61 10 1.000
Location of primary tumor
Colon 57 15 81 13
Rectum 49 8 0.361 79 13 1.000
Tumor depth
≤T3 78 15 110 20
T4 28 8 0.447 50 6 0.493
Histological type
Well, Moderately 98 22 147 25
Poorly, Mucinous 8 1 1.000 13 1 0.696
The number of lymph node metastases
0 42 10 62 5
1-3 45 10 67 16
≥4 19 3 0.844 31 5 0.116
Preoperative CEA (ng/ml)
≤5 74 15 112 14
>5 22 8 0.286 39 4 1.000
Preoperative CA19-9 (U/ml)
≤37 89 21 141 14
>37 4 2 0.340 8 3 0.088
The amount of blood lost (ml)
≤100 50 11 87 10
>100 54 12 1.000 67 16 0.094
Length of operation (min)
≤240 75 13 103 15
>240 29 10 0.210 51 11 0.379
Complication(s)
No 78 15 112 17
Yes 28 8 0.447 47 9 0.647
Infectious complication(s)
No 84 19 120 22
Yes 22 4 1.000 39 4 0.453
The number of hospitalization days (days)
≤17 56 10 92 9
>17 50 13 0.493 68 17 0.035
The number of postoperative days before the initiation of dietary intake (days)
≤3 73 18 120 14
>3 33 5 0.455 40 12 0.034
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low postoperative PNI, which consists of the serum albu-
min concentration and lymphocyte count, correlates with
the survival.
Although attention has been focused on the preopera-
tive status of the host in previous reports, the present
study indicates that the long-term outcome should be
considered to correlate with the postoperative status, as
well as the preoperative status.
In this study, the postoperative PNI tended to correl-
ate with the amount of blood lost during the operation.
Mörner et al. previously reported that the degree of in-
traoperative blood loss was a factor that influenced the
long-term survival [22]. In this study, the amount of
blood lost was associated with the postoperative PNI,
and a low postoperative PNI was associated with poor
survival. These results support the theory that increasing
the amount of intraoperative blood loss could have a
negative impact on the prognosis.
Although it was expected that the postoperative com-
plications which lead to hypoalbuminemia caused by the
systemic inflammatory response or long-term fasting
might correlate with the low postoperative PNI, there
was no relationship found between the postoperative
complications and postoperative PNI in this study. How-
ever, the grade of the postoperative complications was
not taken into consideration in this study. Therefore, it
cannot be concluded that the postoperative complica-
tions and the postoperative PNI are unrelated. Due to
the correlation that was observed in this study between
a low postoperative PNI and an extended number of
hospitalization days and a delay in initiating dietary in-
take, some relationships might exist between a low post-
operative PNI and the lack of a favorable recovery.
Although it has been suggested that the PNI tends to
correlate with age [23, 24] and the preoperative PNI cor-
related with age in this study, the correlation between
the postoperative PNI and age was not seen in this
study. This may be because various postoperative fac-
tors, which were not identified in this study, exceed the
impact of age in terms of the effect on the postoperative
PNI.
There are some possible limitations associated with
this study. First, we evaluated a relatively small number
of patients. Moreover, this study was a retrospective
study, and the criteria for the first visit after leaving the
hospital were not uniform. Therefore, the criteria re-
garding the timing of measuring the PNI was also not
uniform. A large, prospective study should therefore be
performed to confirm our findings.
Conclusions
In this study, the postoperative PNI was demonstrated to
be a useful predictor of a poor prognosis in patients with
CRC. This result confirmed that the postoperative nutri-
tional and immunological status are important when con-
sidering the long-term outcome.
Table 4 The relationship between the clinicopathological factors and the preoperative/preoperative PNI in the validation study
(Continued)
Adjuvant chemotherapy
No 78 13 40 5
Yes 28 10 0.131 120 21 0.628
CI confidence interval, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19–9, PNI prognostic nutritional index
Table 5 The correlations between the overall survival and various clinicopathological factors in the validation study
Univariate analysis Multivariate analysis
Hazard Ratio 95 % CI p-value Hazard Ratio 95 % CI p-value
Age (>70 years) 4.070 1.718–9.646 0.001 0.469 0.095–2.313 0.353
Gender (Female) 1.335 0.578–3.085 0.499
Location of primary tumor (Rectum) 0.492 0.208–1.160 0.105
Tumor depth (T4) 1.524 0.668–3.480 0.317 0.625 0.163–2.391 0.492
Histological type (Poorly, Mucinous) 4.230 1.567–11.417 0.004 7.723 1.057–56.416 0.044
The number of lymph node metastases (≥4) 4.356 1.920–9.882 <0.001 5.707 1.279–25.465 0.022
Preoperative CEA (>5 ng/ml) 2.709 1.086–6.757 0.033 4.355 1.090–17.394 0.037
Preoperative CA19-9 (>37 U/ml) 1.740 0.401–7.538 0.459
Adjuvant chemotherapy (None) 0.399 0.093–1.707 0.215 1.110 0.198–6.230 0.906
The amount of blood lost (>100 ml) 0.794 0.335–1.882 0.600 0.271 0.070–1.050 0.059
Combination of pre and postoperative PNI (<43) 2.019 1.327–3.072 0.001 2.542 1.490–4.337 0.001
CI confidence interval, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19–9, PNI prognostic nutritional index
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